Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 March 2023 | Story Kekeletso Takang and Lacea Loader | Photo UFS Photo Archive
Tate_Makgoe
Tate Makgoe, late MEC of Education in the Free State.

The management of the University of the Free State (UFS) is shocked and saddened to learn of the untimely passing of Tate Makgoe, member of the Executive Council (MEC) for Education in the Free State, who passed away on Sunday 5 March 2023 after a car accident.

MEC Makgoe was a UFS Council member as representative of the Free State Premier for two terms, from 1 November 2010 to 31 December 2018. He was also a member of the Executive Committee of Council in his second term.

“On behalf of the UFS Council, the university management, and the university community, I would like to express our heartfelt condolences to MEC Makgoe’s family, Premier Mxolisi Dukwana, and the Executive Council of the Free State, as well as the Free State education sector at large, for the loss of a great leader,” said Prof Francis Petersen, UFS Rector and Vice-Chancellor.  

MEC Makgoe had a strong relationship with the UFS, which saw him collaborating on numerous projects, including the Internet Broadcast Project from 2012 to 2022, which was aimed at supporting Grade 12 learners and teachers.

Prof Petersen acknowledged MEC Makgoe for his contributions to the university, the institution’s Council, and the province’s education sector. “We are proud to have been associated with MEC Makgoe. Not only in his capacity as MEC, but also as alumnus. He held an Honours degree in Commerce from the UFS and was registered for a PhD in Education Leadership and Policy Studies at the university at the time of his passing. In 2013, he received a Cum Laude Award during the Chancellor's Distinguished Alumni Awards ceremony,” said Prof Petersen.

Through continued collaboration and under his leadership, the Free State reclaimed its top spot in the National Senior Certificate examination results in 2019 and has maintained it to date. “This would not have been possible without the leadership of MEC Makgoe; we salute him for the significant role he played, and for his contribution to the success of the province over the past few years,” said Prof Petersen.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept